COVID – 19 LATEST UPDATES
SEQENS mobilizes its innovation to support the unprecedented research on the covid-19 and prepares its unique industrial network for anti-virus production, for…
Read moreOur research centers, pilot plants and production facilities are fully dedicated to the development and production of active ingredients, pharmaceutical intermediates and…
Read moreProtéus-By-Seqens team, located in Nîmes (France), is pleased to announce having achieved the “Gold” level following the evaluation of its Corporate Social…
Read moreAs a key player in pharmaceutical synthesis and specialty ingredients, Seqens deploys all its know-how to provide its customers with quality products.
Read moreWith more than 50 years of experience in up-scaling and custom manufacturing of small molecules and polymers, SEQENS Advanced Specialties offering a…
Read moreOur La Madeleine site of Seqens Mineral Specialties division has developed a document sharing platform for its customers, known as “Qualit-e”.
Read moreFor the third consecutive year, we presented our group at the prestigious “J.P. Morgan Healthcare Conference 2021“. This year…
Read moreIn October 2019, in partnership with the laboratory LORIA*, Harmonic Pharma, located in the startup area of Mines Nancy, started the Chemical…
Read moreThe Seqens Mineral Specialties team proposes you a recipe of gingerbread with our sodium bicarbonate manufactured on our production sites. SODIUM BICARBONATE AND…
Read moreSEQENS Mineral Specialties produces high-quality Sodium Bicarbonate grades to serve the growing worldwide demand in pharmaceutical, food and feed markets.
Read moreAs a global player in pharmaceutical synthesis and specialty ingredients, SEQENS is committed to making the fight against global warming one…
Read more